Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Obesity Surgery
Literature
1.
Gui D, De Gaetano A, Spada PL, et al. Botulinum toxin injected in the gastric wall reduces body weight and food intake in rats. Aliment Pharmacol Ther. 2000;14(6):829–34.CrossRefPubMed
2.
Coskun H, Duran Y, Dilege E, et al. Effect on gastric emptying and weight reduction of botulinum toxin-a injection into the gastric antral layer: an experimental study in the obese rat model. Obes Surg. 2005;15:1137–43.CrossRefPubMed
3.
Rollnik JD, Meier PN, Manns MP, et al. Antral injections of botulinum a toxin for the treatment of obesity. Ann Intern Med. 2003;18;138(4):359–60.
4.
Elshakh H, El-Ejji K, Taheri S. The role of endoscopic intra-gastric botulinum toxin-a for obesity treatment. Obes Surg. 2017;27(9):2471–8.CrossRefPubMed
5.
Bustamante F, Brunaldi VO, Bernardo WM, et al. Obesity treatment with botulinum toxin-a is not effective: a systematic review and meta-analysis. Obes Surg. 2017;27(10):2716–23.CrossRefPubMed
6.
De Moura EGH, Ribeiro IB, Frazão MSV, et al. EUS-guided intragastric injection of botulinum toxin a in the preoperative treatment of super-obese patients: a randomized clinical trial. Obes Surg. 2019;29(1):32–39.
7.
8.
9.
Dorner MB, Wilking H, Skiba M, et al. A large travel-associated outbreak of iatrogenic botulism in four European countries following intragastric botulinum neurotoxin injections for weight reduction, Türkiye, February to March 2023. Euro Surveill. 2023;8;28(23):2300203.
10.
Metadata
Title
The Controversy Surrounding Botulinum Neurotoxin (BONT) as a Weight Loss Intervention in Turkish Healthcare Realities
Author
Halil Coskun
Publication date
28-02-2024
Publisher
Springer US
Keyword
Botulinum Toxin
Published in
Obesity Surgery / Issue 4/2024
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-024-07132-5

Other articles of this Issue 4/2024

Obesity Surgery 4/2024 Go to the issue

Original Contributions

Effects of Probiotic Use on Gastrointestinal Symptoms in the Late Postoperative Period of Bariatric Surgery: A Cross-Over, Randomized, Triple-Blind, Placebo-Controlled Study

Letter to the Editor

GLP-1 Receptor Agonists in Weight Loss and Bariatric Surgery: Balancing Efficacy and Gastrointestinal Adverse Events

Original Contributions

The impact of Aprepitant on Nausea and Vomiting following Laparoscopic Sleeve Gastrectomy: A Blinded Randomized Controlled Trial

Original Contributions

Extended Post Discharge Prophylaxis for Venous Thromboembolism Prevention After Bariatric Surgery

Original Contributions

Factors Associated with Statin Discontinuation Following Metabolic and Bariatric Surgery: A Retrospective Analysis of 2012–2021 Electronic Medical Records Network Data

Correction

Correction: Bismuth-Based Therapy: The New Therapy for Obese Patients Undergoing Gastric Bypass Surgery?